Companies · DD
DuPont
AI-generated · informational only · not investment advice · verify before relying.
Latest analysis
Updated Nov 3, 2026
DuPont posts 4% organic sales growth in Q3 2026 as post-separation portfolio delivers margin expansion across both segments
DuPont's continuing operations — now comprising Healthcare & Water Technologies and Diversified Industrials — delivered $1.87 billion in Q3 2026 net sales, up 4% year-over-year, with Operating EBITDA margins expanding as cost of sales as a percentage of net sales fell from 66% to 64% driven by manufacturing productivity. The Aramids Divestiture (completed April 1, 2026) and Electronics Separation (completed November 1, 2025) are now fully reflected as discontinued operations, leaving a leaner two-segment structure generating $1.04 billion in operating cash flow through nine months. PFAS legacy liability crystallization — with the New Jersey and North Carolina settlements now judicially approved and payments commenced — represents the most consequential new financial obligation disclosed this quarter, with DuPont's gross future contractual cash outflows totaling $365 million beyond Q3 2026.
Tone: cautiousRevenue
$6.8B
DD 10-K · FY 2025
Employees
15,000
Revenue FY2024
$12.4B
Founded
2015
Profile
DD 10-K Item 1 · Feb 17, 2026DuPont de Nemours is an advanced materials and solutions company serving healthcare, water, construction, and industrial end markets. Following the November 2025 spin-off of its electronics business into Qnity Electronics, the company operates two segments: Healthcare & Water Technologies and Diversified Industrials. Its portfolio spans medical packaging, water filtration, building insulation, structural adhesives, and specialty lubricants.
Read filing description ↓ Collapse description ↑
DuPont is a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. The Company is committed to helping customers advance their technology pipelines and provide solutions that address their unique challenges. From delivering clean water to enabling medical packaging solutions which enhance safety and performance, DuPont's innovations power the essential products and technologies people rely on every day. At December 31, 2025, the Company has subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. Healthcare & Water Technologies includes high-performance packaging, parts and components for medical device and biopharma markets as well as water filtration and purification technologies primarily for industrial wastewater & energy, municipal drinking water & desalination, and life sciences & specialty markets. Diversified Industrials includes building technologies, with a broad portfolio serving new-build and repair/remodel applications across non-residential and residential construction markets, and industrial technologies, which includes a portfolio of adhesive, wear and friction, and packaging solutions serving aerospace, automotive and printing and packaging markets. The Company leverages application development expertise, specialized manufacturing capabilities, and recognized brands to support customers' product development, scale-up, and operational requirements across regulated and mission-critical applications.
Primary products
- TYVEK medical packaging and garments
- TYCHEM protective suits
- AMBERLITE ion exchange resins
- FILMTEC reverse osmosis and nanofiltration elements
- INGE ultrafiltration modules
- ITEGRATEC ultrafiltration modules
Business segments
End markets
Geographies
“The Company believes that its proprietary product and process technologies, robust product and application development pipelines, well-known brands, customer intimacy, global manufacturing capability, and local service capability help strengthen its competitive position and enable it to compete successfully.” Competitive position, as stated in the filing
Revenue commentary · FY 2025
Total net sales grew from $6,719 million in 2024 to $6,849 million in 2025, reflecting growth in Healthcare & Water Technologies partially offset by a decline in Diversified Industrials.
The rest of DD is for subscribers
Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.